One pedal stroke at a time, more than 300 cyclists, all Bristol Myers Squibb employees, from more than 30 markets around the world will bicycle this September through December across the United States, Europe, Asia Pacific and Latin America with one collective mission – to advance cancer research.

Starting September 10 through October 7, more than 100 Bristol Myers Squibb colleagues will pedal in a 3,000 mile-relay from Cannon Beach, Oregon to Long Branch, New Jersey to advance cancer research as part of an annual bicycle ride known as C2C4C United States which is in its 13th year with a goal of raising more than $1 million for the V Foundation for Cancer Research.

C2C4C

“C2C4C brings together something powerful – people pushing themselves to the limit and a shared commitment to advancing cancer research,” said Susanna Greer, Ph.D., chief scientific officer at the V Foundation for Cancer Research. “The dedication of Bristol Myers Squibb and its employees, both on the road and in their fundraising efforts, plays a meaningful role in accelerating the research that patients are waiting for.”

The C2C4C bike ride goes well beyond the United States. In total, more than 300 Bristol Myers Squibb employees representing more than 30 markets nations will bicycle in similar C2C4C rides in Europe, Asia Pacific, and Latin America that will benefit cancer organizations that are members of the Union for International Cancer Control.

“I’ve had the honor of participating in C2C4C in Europe, the United States and Asia Pacific, and it’s an incredibly powerful experience – from the connection you forge with your fellow riders to the people and stories you gather along the way,” said Chris Boerner, board chair and CEO, Bristol Myers Squibb. “I’m inspired by my colleagues cycling in this 13th year for family, friends and cancer patients. They embody our purposeful, patient-centric culture on a worldwide stage.”

In the United States, military veteran and cancer survivor Joe Bolger, a senior therapeutic specialist from Ohio, will participate in C2C4C for the second time in seven years.

“In 2017, I was diagnosed with prostate cancer. In 2019, I rode in C2C4C for my father and mother-in-law,” said Bolger. “I’m honored to ride again in 2026. There is much work to be done when it comes to cancer research and helping patients live longer lives.”

An avid cyclist, Bolger will serve as a team captain and ride in 2026 from Topeka, Kansas to St. Louis, Missouri.

“The camaraderie that you build, the bonds, the new friendships, will stay with you forever, and I hope that everyone can experience what I’ve experienced. That they can walk away from this saying they want to reapply next year,” added Bolger.

In C2C4C Europe, cancer survivor Peggy Somers, an HCP strategist, oncology from Belgium will participate again in C2C4C.

“C2C4C is deeply personal for me,” said Somers. “After facing cancer myself and riding my first C2C4C, this challenge has taken on an even deeper meaning. Participating again is about honoring resilience, hope and everyone touched by cancer.”

C2C4C is in its 13th year and since its inception, has raised more than $21 million to advance cancer research worldwide. 

“We are very grateful to Bristol Myers Squibb for continuing to direct proceeds from the C2C4C rides…and to all their employees who will cycle and commit their time and energy to support cancer organizations in their communities,” said Dr. Cary Adams, CEO of UICC. “The funds raised via C2C4C will help address important gaps in access to cancer services.”

To learn more, visit: https://www.bms.com/life-and-science/insights/c2c4c-2026-cancer-research.html

That’s it for this post. If you like what you read, follow us on Instagram or Facebook using the buttons above. To help us create more inspiring content, please donate to Greater Than The Game using the button below.